Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1997-12-01
1999-01-26
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514556, A61K 31205, A61K 31225
Patent
active
058639403
ABSTRACT:
A therapeutical method is disclosed for treating idiopathic asthenozoospermia which comprises orally or parenterally administering to a patient in need thereof a combination preparation comprising in admixture L-carnitine and acetyl L-carnitine or the pharmacologically acceptable salts thereof, in substantially equimolar amouts.
REFERENCES:
R. Golan, et al., "Influence of various substrates on the acetylcarnitine:carnitine ratio in motile and immotile human spermatozoa", Reprod. Fert. (1986) 78, 287-293.
Sava R. Micic, et al., "Seminal Carnitine and Glucosidase in Oligospermic and Azoospermic Men", Journal of Andrology, vol. 15, Supplement 1994, p. 77S.
Koji Ashizawa, et al., "Inhibition of Flagellar Motility of Fowl Spermatozoa by L-Carnitine: Its Relationship with Respiration and Phosphorylation of Axonemal Proteins", Molecular Reproduction and Development, 38:318-325 (1994).
C. Jeulin, et al., "Uptake and release of free L-carnitine by boar epididymal spermatozoa in vitro and subsequent acetylation rate", Journal of Reproduction and Fertility, (1994), 100:263-271.
R. Deana, et al., "Effect of L-carnitine and L-Aminocarnitine on Calcium Transport, Motility, and Enzyme Release from Ejaculated Bovine Spermatozoa", Biology of Reproduction, 41:949-955 (1989).
A. Lee Carter, et al., "A factor in human seminal plasma which affects carnitine accumulation in bovine epididymal sperm", Fertility and Sterility, vol. 49, No. 5, May, 1988.
Claudette Jeulin, et al., "Acetylcarnitine et spermatozoides: relation avec la maturation epididymaire et la mobilitechez le varrat et l'homme", Reprod. Nutr. Develop., 1988, 28(5):1317-1328.
M. Bartellini., et al., "L-carnitine and acetylcarnitine in human sperm with normal and reduced motility", Europaea Fertilitatis, vol. 18, No. 1, 1987, pp. 29-31.
D.P. Shalev, "Investigation on the Motility of Human Spermatozoa in a Defined Medium in the Presence of Metabolic Inhibitors and of Carnitine", Andrologia 18(4):368-375 (1986).
G. Abbaticchio, et al., "Free L-carnitine in humn semen", Archives of Andrology 15:137-142 (1985).
G.F. Menhini-Fabris, et al., "Evaluation of Human Seminal Carnitine Content in the Pathophysiology of Reproduction", 3d International Forum of Andrology, Paris, France, Jun. 18-19, 1985.
G. Fabrizio Menhini-Fabris, et al., "Free L-carnitine in human semen: its variability in different andrologic pathologies", Fertility and Sterility, vol. 42, No. 2, pp. 263-267, Aug., 1984.
David A. I. Suter, et al., "The concentrations of free L-carnitine and L-O-Acetylcarnitine in spermatozoa and seminal plasma of normal, fresh, and frozen human semen", Fertility and Sterility, vol. 31, No. 5, Mar., 1979, pp. 541-544.
S. Kohengkul, et al., "Levels of L-carnitine and L-O-Acetylcarnitine in normal and infertile human semen: a lower level of L-O-Acetylcarnitine in infertile semen", Fertility and Sterility, vol. 28, No. 12, Dec., 1977, pp. 1333-1336.
R. Amendola, et al., "Effects of L-acetylcarnitine (LAC) on the Post-Injury Recovery of Mouse Spermatogenesis monitored by Flow Cytomertyr 1. Recovery after X-Irradiation", Andrologia 21, (6):568-575 (1989).
G. Vitali, et al., "Carnitine Supplementation in Human Idiopathic Asthenospermia: Clinical Results", Drugs Exptl. Clin. Res. XXI(4) 157-159 (1995).
S. Micic, et al., "Does L-carnitine adminstered in vivo improve sperm motility?", ARTA 1995, vol. 7, pp. 127-130.
M. Costa, et al., "L-carnitine in idiopathic asthenozoospermia: a mulitcenter study", Andrologia 26, 155-159, 1994.
"Diagnostica Andrologica e Fisiopathologia della Riproduzione" 1995, Colle di Mezzo srl--Tutti i Diritti sono Riservati.
"Federation Proceedings--Abstract" 57.sup.th Annual Meeting, Atlantic City, New Jersey, Apr. 15-20, 1973: p. 528.
Amendola et al, Andrologia, 21(6), 568-75 (Abstract), 1989.
Vitali et al, Drugs. Exp. Clin. Res, 21(4) 157-9 (Abstract), 1995.
Schenkman Leonard
Sigma-Tau HealthScience S.p.A.
LandOfFree
Medicament and therapeutical method for treating idiopathic asth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament and therapeutical method for treating idiopathic asth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament and therapeutical method for treating idiopathic asth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1450774